Current position:Home >Product >
4-((4-Methylphenyl)amino)-4-oxobutanoic acid compd. with 4,5-dihydro-2 -thiazolamine (1:1)
4-((4-Methylphenyl)amino)-4-oxobutanoic acid compd. with 4,5-dihydro-2 -thiazolamine (1:1)(171088-73-6)
- Name: 4-((4-Methylphenyl)amino)-4-oxobutanoic acid compd. with 4,5-dihydro-2 -thiazolamine (1:1)
- Synonyms:AmbscPOD_07/0759;
- Molecular Formula:C14H19N3O3S
- Molecular Weight:309.384
- CAS Registry Number:171088-73-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.171088-73-6 4-((4-Methylphenyl)amino)-4-oxobutanoic acid compd. with 4,5-dihydro-2 -thiazolamine (1:1)
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]

Other Product
- 21322-85-0/4-{[(2-chloro-4-nitrobenzyl)carbamoyl]amino}-3-methylbenzenesulfonyl fluoride
- 52051-38-4/Colistin, hydrochloride
- 85252-02-4/Hexanedioic acid, bis(2-(2-(2-(C12-13-alkyloxy)ethoxy)ethoxy)ethyl) ester
- 154971-10-5/Dammar-23-en-16-one,3-(a-L-arabinopyranosyloxy)-30-(b-D-glucopyranosyloxy)-20,25-dihydroxy-,(3b,23E)- (9CI)
- 18678-30-3/2-phenyl-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one
- 13716-89-7/H-GLU-GLY-OH
- 66147-40-8/N-[4-(7-carboxyheptyl)phenyl]acridin-9-aminium chloride
- 63814-25-5/13,14-dihydro-16-phenyl-omega-tetranorprostaglandin E2
- 64398-71-6/8-amino-5-methyl-6-phenylphenanthridinium
- 68937-80-4/Fatty acids, C16-20 and C16-18-unsatd, Me esters
- 4229-56-5/1,4-Dihydronicotinamide mononucleotide
- 115035-50-2/Fatty acids, C6-10, Me esters, polymers with adipic acid, 1,4-butanediol and propylene glycol
- 58088-57-6/PHENYL-PYRIDIN-4-YLMETHYL-AMINE
- 145039-10-7/Olean-12-en-28-oic acid,27-hydroxy-3-oxo-
- 117332-63-5/5H-Azeto[1,2-a]indolo[3''',2''':4'',5'']azocino[1'',2'':4',5']pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-10,20(6H,10aH)-dione,11,11a,17,18-tetrahydro-10a,11a-dihydroxy-11-methoxy-6,6,17,17,18-pentamethyl-,(10aS,11S,11aR,18R,18aS)-
- 63991-19-5/4-Hexyl-α-(piperidinomethyl)benzyl alcohol
- 85057-78-9/5-(ethoxycarbonyl)-3,4-dimethyl-1H-pyrrole-2-carboxylic acid
- 22123-15-5/2-chloro-6-(thiophen-2-yl)-4-(trifluoromethyl)pyridine
- 37256-83-0/Naphthalene oxygenase
- 171088-73-6/4-((4-Methylphenyl)amino)-4-oxobutanoic acid compd. with 4,5-dihydro-2 -thiazolamine (1:1)
- 139223-25-9/2,2-Methylenebis(5-(4,5-dihydro-1H-imidazol-2-yl)-1H-benzimidazole)
- 84434-21-9/1,1-bis[(3,7-dimethyloct-6-enyl)oxy]-2-methylundecane
- 63331-28-2/1-propargyl-5-bromopyrimidin-2-one
- 15401-05-5/1-Pyrrolidinecarboxylicacid,2-[[(1R)-1-[[(2R,3R,11bS)-3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]quinolizin-2-yl]methyl]-3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl]carbonyl]-,phenylmethyl ester, (2S)-
- 56185-70-7/2-[2,2-bis(methylsulfanyl)ethenyl]-1-methylpyridinium iodide
- 79147-69-6/Virolanol B
- 68784-53-2/Tungstate calcium (T-4)-lead-doped
- 4314-32-3/N-ethenyl-2,2,3,3,4,4,4-heptafluorobutanamide
- 53486-15-0/1-acetyl-10-butyl-7,8-dimethoxy-3-(phenylamino)phenazin-2(10H)-one
- 7241-13-6/sulphonylbis[tribromomethane]